Expression, purification and characterization of the cancer-germline antigen GAGE12I: A candidate for cancer immunotherapy

Protein Expression and Purification

Volumn 73, Issue 2, 2010, Pages 217-222

  Gjerstorff, Morten F ^a,c   Besir, Hüseyin ^b   Larsen, Martin R ^c   Ditzel, Henrik J ^c,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Protein Expression and Purification Core Facility   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cancer germline antigen; Cancer testis antigen; GAGE; Immunotherapy; Pichia pastoris

Indexed keywords

CANCER VACCINE; GAGE7 PROTEIN, HUMAN; HISTIDINE; PROTEIN; RECOMBINANT PROTEIN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; CHEMISTRY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; MALE; METABOLISM; METHODOLOGY; NEOPLASM; PICHIA;

ANTIGENS, NEOPLASM; CANCER VACCINES; FEMALE; HISTIDINE; HUMANS; IMMUNOTHERAPY; MALE; NEOPLASM PROTEINS; NEOPLASMS; PICHIA; PROTEINS; RECOMBINANT PROTEINS;

PICHIA PASTORIS;

EID: 77955432353     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.05.010     Document Type: Article

References (19)

1. A.J. Simpson, O.L. Caballero, A. Jungbluth, Y.T. Chen, and L.J. Old Cancer/testis antigens, gametogenesis and cancer Nat. Rev. Cancer 5 2005 615 625
2. O.L. Caballero, and Y.T. Chen Cancer/testis (CT) antigens: potential targets for immunotherapy Cancer Sci. 100 2009 2014 2021
3. B.J. Stevenson, C. Iseli, S. Panji, M. Zahn-Zabal, W. Hide, L.J. Old, A.J. Simpson, and C.V. Jongeneel Rapid evolution of cancer/testis genes on the X chromosome BMC Genomics 8 2007 129
4. M.F. Gjerstorff, and H.J. Ditzel An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members Tissue Antigens 71 2008 187 192
5. O. De Backer, K.C. Arden, M. Boretti, V. Vantomme, C. De Smet, S. Czekay, C.S. Viars, E. De Plaen, F. Brasseur, P. Chomez, B. Van den Eynde, T. Boon, and P. Van der Bruggen Characterization of the GAGE genes that are expressed in various human cancers and in normal testis Cancer Res. 59 1999 3157 3165
6. S. Eichmuller, D. Usener, D. Thiel, and D. Schadendorf Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity Int. J. Cancer 104 2003 482 487
7. A. Gerhardt, D. Usener, M. Keese, J. Sturm, D. Schadendorf, and S. Eichmuller Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer Cancer Lett. 208 2004 197 206
8. U. Kong, J. Koo, K. Choi, J. Park, and H. Chang The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer Hepatogastroenterology 51 2004 1519 1523
9. I.Y. Cheung, S.N. Chi, and N.K. Cheung Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma Med. Pediatr. Oncol. 35 2000 632 634
10. A. Zambon, S. Mandruzzato, A. Parenti, B. Macino, P. Dalerba, A. Ruol, S. Merigliano, G. Zaninotto, and P. Zanovello MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia Cancer 91 2001 1882 1888
11. R.K. Kular, F. Yehiely, K.U. Kotlo, Z.M. Cilensek, R. Bedi, and L.P. Deiss GAGE, an antiapoptotic protein binds and modulates the expression of nucleophosmin/B23 and interferon regulatory factor 1 J. Interferon Cytokine Res. 29 2009 645 655
12. Z.M. Cilensek, F. Yehiely, R.K. Kular, and L.P. Deiss A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, interferon-gamma, taxol and gamma-irradiation Cancer Biol. Ther. 1 2002 380 387
13. + T-cell-mediated immunity and protection against NY-ESO-1+ tumors Clin. Cancer Res. 10 2004 2879 2890
14. I.D. Davis, W. Chen, H. Jackson, P. Parente, M. Shackleton, W. Hopkins, Q. Chen, N. Dimopoulos, T. Luke, R. Murphy, A.M. Scott, E. Maraskovsky, G. McArthur, D. MacGregor, S. Sturrock, T.Y. Tai, S. Green, A. Cuthbertson, D. Maher, L. Miloradovic, S.V. Mitchell, G. Ritter, A.A. Jungbluth, Y.T. Chen, S. Gnjatic, E.W. Hoffman, L.J. Old, and J.S. Cebon Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans Proc. Natl. Acad. Sci. USA 101 2004 10697 10702
15. Q. Zhou, A.L. Guo, C.R. Xu, S.J. An, Z. Wang, S.Q. Yang, and Y.L. Wu A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro Clin. Exp. Immunol. 153 2008 392 400
16. V. Vantomme, C. Dantinne, N. Amrani, P. Permanne, D. Gheysen, C. Bruck, G. Stoter, C.M. Britten, U. Keilholz, C.H. Lamers, M. Marchand, M. Delire, and M. Gueguen Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors J. Immunother. 27 2004 124 135
17. V.G. Brichard, and D. Lejeune GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development Vaccine 25 Suppl. 2 2007 B61 B71
18. M.F. Gjerstorff, L.E. Johansen, O. Nielsen, K. Kock, and H.J. Ditzel Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy Br. J. Cancer 94 2006 1864 1873
19. J.L. Cereghino, and J.M. Cregg Heterologous protein expression in the methylotrophic yeast Pichia pastoris FEMS Microbiol. Rev. 24 2000 45 66